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Hormonal modifications in patients admitted to an 
internal intensive care unit for acute hypoxaemic 
respiratory failure 
T. KULLMER*, T. HAAK, B. R. WINKELMANN, D. MORBITZER, E. JUNGMANN AND 
J. MEIER-SYDOW 
Departments of Internal Medicine I and IV, J. W. Goethe University, Frankfurt am Main, Germany 
To clarify which endocrine modifications can be observed in acute hypoxaemic respiratory failure, 15 severely 
ill male patients [PAT; median age: 61 (range: 48 years); median height: 173 (range: 12) cm; median mass: 73 
(range 31) kg] were investigated immediately upon admission to an intensive care unit (ICU) for this clinical 
disorder. Before starting treatment, the blood gases were measured and a number of selected hormones with 
special relevance for an ICU setting were determined. These are known to be modified by acute hypoxaemia 
in healthy subjects and to possess glucoregulatory properties, or an influence upon cardiocirculation or the 
vascular volume regulation: insulin, cortisol, adrenaline, noradrenaline, atria1 natriuretic peptide, renin, 
aldosterone, angiotensin converting enzyme, and endothelin-I (ET). To elucidate whether potential endocrine 
changes resulted from acute hypoxaemia alone, the underlying disease, or unspecific influences connected with 
the ICU setting, all measurements were compared to those of a completely healthy reference group (REF) 
with comparable acute experimental hypoxaemia. The latter state was achieved by having the REF breathe a 
gas mixture with the oxygen content reduced to 14% (H). 
In the REF, neither the medians nor the distribution of endocrinologic measurements were modified 
significantly by acute hypoxaemia. In the PAT, the medians were increased considerably, yet with a slight 
diminution of ET. The distribution of individual values was considerably broader than in the REF with H. 
In conclusion, considerable increases in the means of the above hormones, with the exception of ET, can be 
registered in severely ill patients admitted to ICUs with acute hypoxaemic failure. However, such modifica- 
tions cannot be considered attributable exclusively to acute arterial hypoxaemia. The underlying clinical 
disorders, such as septicaemia or an unspecific endocrine epiphenomenon, including severe and not only 
hypoxaemic stress, seem to be predominant. 
Introduction 
A multitude of recent studies have reported on 
hormonal modifications associated with various 
severe non-endocrine clinical disorders, such as car- 
diocirculatory failure or other forms of shock (l-5). 
Acute hypoxaemic respiratory failure, i.e. 
‘hypoxic’ hypoxaemia (Barcroft), is one of the most 
frequent severe clinical conditions seen in internal 
intensive care units (ICUs). A wide variety of effects 
on the cardiopulmonary system, as well as on other 
organs and tissue, associated with acute arterial 
hypoxaemia have been reported in the literature (6). 
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Among these, there are also various endocrine 
modifications (7-l 1). However, the majority of find- 
ings on cardiocirculation and gas exchange, as well 
as endocrinologic reports, pertaining to acute 
hypoxaemia have been gathered in healthy subjects at 
high altitude (12-14). Not surprisingly, the author of 
a well-known handbook on pulmonary medicine has 
pointed out that the ‘understanding of the effects (of 
acute hypoxaemia) is derived from studies conducted 
primarily in normal humans (. . and that) they may 
be different in diseased humans’ (6). 
Aims of the Study 
This study intended to clarify whether modifica- 
tions in the blood levels of the catecholamines, atria1 
natriuretic peptide, endothelin-I, cortisol, insulin, 
c-peptide, renin, aldosterone and angiotensin- 
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Table I Age, physical characteristics and clinical diagnoses of the patients 
Patient Age Mass Height 
no. (years) (kg) (cm) Clinical diagnoses 
1 52 89.2 171 
2 33 58.0 168 
3 63 60.1 167 
4 47 67.0 177 
5 73 64.0 173 
6 36 64.0 172 
7 50 83.0 177 
8 51 75.0 172 
9 69 73.0 170 
10 61 70.0 175 
11 64 92.0 173 
12 41 77.3 175 
13 67 82.0 178 
14 62 75.6 170 
15 81 85.0 166 
i? 61 73 173 
R 48 31 12 
Hypoxaemia. Pneumonia. Septicaemia. Reconvalescence phase after chemotherapy 
for AML. 
Hypoxaemia. Pneumonia. Septicaemia. Positive HIV-serology, endocarditis. 
Hypoxaemia. Pneumonia. Chronic renal failure. 
Hypoxaemia. Pneumonia. Reconvalescence after aortic valvular replacement. 
Hypoxaemiu. Pneumonia. Intrapulmonary and skeletal metastases of unknown 
primary tumour. 
Hypoxaemia. Pneumonia. Septicaemia. Positive HIV-serology. 
Hypoxaemia. Pneumonia. Septicaemia. Diabetes mellitus II. 
Hypoxaemia. Pneumonia. Coronary heart disease. 
Hypoxaemia. Pneumonia. Intrathoracic of the aorta. aneurysm 
Hypoxuemia. Pneumonia. 
Hypoxaemiu. Pneumonia. Ipsilateral intrapulmonary tumour. 
Hypoxaemia. Pneumonia. Delirium tremens with alcohol withdrawal. 
Congestive cardiomyopathy. 
Hypoxaemia. Pneumonia. Coronary heart disease. 
Hypoxaemia. Pneumonia. Intoxication with a benzodiazepine, aspiration of sputum. 
Septicaemia. 
Hypoxaemia. Pneumonia. Septicaemia. Bleeding from a colonic diverticula. 
Coronary heart disease. 
Acute clinical disorders on admission in italic type; chronic diseases in regular type. 
converting enzyme were associated with acute arterial 
hypoxaemia of the ‘hypoxic’ type (Barcroft), based 
on respiratory failure in pulmonary intensive care 
patients. The hormones investigated possess a special 
relevance for an ICU setting; they are known to be 
modified by acute hypoxaemia in healthy subjects 
and to possess either glucoregulatory properties, or 
an influence upon cardiocirculation or the vascular 
volume regulation. 
In addition, this study intended to clarify whether 
such endocrine modifications resulted from acute 
arterial hypoxaemia alone, or could also be attributed 
directly to the underlying disease or to other unspe- 
cific influences connected with admission to the ICU. 
Patients, Test Persons and Experimental Procedure 
Fifteen male patients (PAT) admitted to an inter- 
nal ICU for acute hypoxaemic respiratory failure 
were included in the study. Their age, physical char- 
acteristics and clinical diagnoses of acute and chronic 
diseases are given in Table 1. Physical examination, 
pulmonary infiltrates in the chest X-rays and micro- 
biological investigations conducted in blood or 
sputum had indicated that the leading diagnosis was 
pneumonia. Hypoxaemia was therefore attributed to 
acute respiratory failure. No recent blood gas 
measurements had been performed in any of the 
patients prior to admission to the ICU. Since the 
leading clinical symptom of dyspnoea had existed for 
no longer than 24 h prior to clinical admission in 
every case, arterial desaturation was characterized as 
acute hypoxaemia. 
Immediately upon admission to the ICU and well 
before any treatment was started, including the 
administration of oxygen, artificial ventilation or 
sedation, the following diagnostic measurements 
were performed. The blood gases were measured and 
a number of selected endocrinologic and metabolic 
variables were determined in venous blood samples, 
with the patients breathing normal air (see Methods) 
and resting in a supine position. In addition, heart 
rate was registered with an ECG, and blood pressure 
was measured with a sphygmomanometer. The per- 
tinent results will not be discussed in detail in this 
paper unless of immediate interest for the topic of this 
investigation. 
In order to be able to pursue the second aim of 
this investigation, a reference group of completely 
healthy, non-smoking test persons was also investi- 
gated. Gender, age and physical characteristics of the 
reference group [REF; median age: 25 (range: 10) 
years; median height: 180 (range: 16); median mass: 
70 (range: 43) kg] were chosen explicitly to resemble 
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groups of subjects which had been investigated pre- 
viously in experiments on acute hypoxaemia at high 
altitude and upon which the present pertinent knowl- 
edge is predominantly based (6). The members of the 
reference group were free of cardiopulmonary disease 
and relevant allergies, and had shown normal results 
in spirometry and blood gas analysis. 
In random order and in a single-blind experimental 
setting, the REF were to breathe normal air on 1 day 
(N; Fro,: 0.21) and a gas mixture with reduced 
oxygen content on another day (H; FIO,; 0.14) (15). 
On both test days, the respective inspiratory gases 
were applied to REF, who also rested in a supine 
position, in a single-blind fashion under normal 
ambient pressure over 60 min. For this purpose, a 
face mask with unidirectional inspiratory and expira- 
tory valves was used. Thus on H day, acute arterial 
desaturation was produced experimentally and was 
assigned uniformly to the ‘hypoxic’ type of acute 
hypoxaemia (Barcroft classification). In the REF, 
those laboratory variables which had already been 
assessed in the patients (see next section) were deter- 
mined under fasting conditions in the last 10 min of 
this period. 
Methods 
In 5;ul samples of arterial blood from the a. 
radialis or the a. brachialis (‘Arterial canula with 
FloSwitch@‘, Ohmeda; Swindon, U.K.), the partial 
pressures of oxygen (PaO,) and carbon dioxide 
(PaCO,), and pH values were determined, taking 
into consideration the individual body temperature 
and using a polarographic microanalyser (AVL 939; 
Bad Homburg, Germany). 
Duplicate measurements of the following hor- 
mones were performed in blood samples taken from 
the antecubital vein through an indwelling catheter 
(Abbocatha), using commercially available radio- 
immunoassays: Insulin (INS; Pharmacia, Freiburg, 
Germany), C-peptide (CP; Diagnostic Products, Los 
Angeles, U.S.A.), cortisol (CORT; Travenol Baxter, 
Unterschleissheim, Germany) (16), atria1 natriuretic 
peptide (ANP, ITS, Wijchen, The Netherlands) (17), 
renin (PRA; Serono, Freiburg, Germany) and aldos- 
terone (PA; Biermann, Bad Nauheim, Germany). 
For the determination of endothelin-I (ET), blood 
from the cubital vein was collected in ice-chilled 
ethylenediaminetetraacetate-coated tubes, centri- 
fuged at 1500 g for 20 min, and the plasma frozen at 
- 70°C until analysis. Endothelin-I was extracted via 
SepPak Cl8 cartridges (Waters, Millipore; Marlboro, 
U.S.A.) and measured with an endothelin-sensitive 
radioimmunoassay (Biomedica, Vienna, Austria). 
The ET antibody has a cross-reactivity < 1% with its 
precursors, big endothelin, C-terminal hexapeptide 
or sarofotoxin. The activity of the angiotensin- 
converting enzyme (ACE) was assessed with a 
calorimetric assay (18). In addition, adrenaline 
(ADR) and noradrenaline (NOR) were determined 
radioenzymatically (19). 
The intra-assay coefficients of variation were 7.0% 
for the ADR method, 5.0% for NOR, 8.0% for the 
CORT assay, 5.8% for the INS assay, 2.0% for 
the CP assay, 8.6% for the ANP assay, 12.0% for the 
PRA assay, 9.8% for the PA assay, 8.2% for the ACE 
method and 10.0% for the ET assay. Blood counts 
were also performed in the venous blood samples 
for the determination of the leucocyte count. 
Lactate (LA) and glucose (GLU) were determined 
enzymatically in the arterial blood samples (20). 
All data were calculated as medians (2) and ranges 
(R). In a descriptive, explorative approach, non- 
parametrical statistical comparisons were conducted 
between the medians of the measurements referring 
to the PAT and the REF using U-tests. Measure- 
ments in the REF were compared between N day 
and H day using Wilcoxon’s matched pairs signed 
rank tests. The level of statistical significance was set 
at a=0.05. Statistical symbols: *P<O.O5; **P<O.Ol; 
***P<o.ool. 
The experiments were approved by the Committee 
for Ethics in Medicine of Frankfurt University and 
informed consent was obtained from the subjects. 
Results 
In the PAT, the median of PaO, amounted to 58.0 
(range: 31.6) mmHg and differed significantly, yet 
only by a slight margin, from the medians of the REF 
on H day with 50.6 (range: 11.5) mmHg (**), but was 
clearly reduced compared to the normal median 
values of the REF on N day with 95.2 (range: 16.0) 
mmHg (***) (21). The corresponding median values 
of the haemoglobin-O,-saturation (SaO,) were 87.2 
(range: 37.4) % in the PAT and 85.3 (range: 8.7) % in 
the REF on H day, and 97.8 (range: 2.1) % on N day. 
The medians for PaO, and SaO, in the REF seen 
on H day were reduced significantly compared to N 
day (***, respectively), and corresponded to prior 
measurements conducted under similar experimental 
conditions (22). The median of the PaCO, in the 
PAT was 38.9 (range: 17.2 ) mmHg and did not differ 
significantly from the medians in the REF group, 
which were almost similar between both test days 
with 39.2 (range: 13.3) mmHg during H and 40.3 
(range: 12.0) mmHg during N. In the REF, one 
individual measurement was lower than 35 mmHg on 
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Fig. I Comparisons of adrenaline (ADR), noradrenaline (NOR), endothelin-I (ET) and atria1 natriuretic peptide (ANP) 
between the groups of the acutely hypoxaemic patients (PAT) and the reference group (REF) on H day (H) and on N day 
(N), respectively. The horizontal lines in the scatter plots indicate the positions of the medians. See text for statistical 
symbols. Note that logarithmic scales were used on the ordinate. 
each test day. The median pH values were normal 
and did not differ significantly between the PAT with 
7.435 (range: 0.280) and the values of the REF with 
7.435 (range: 0.108) on H day, nor with 7.410 (range: 
0.088) on N day (21). The variability of the blood gas 
measurements in the PAT was higher than in the 
REF. 
In the REF, all endocrinologic measurements were 
within the normal limits of the authors’ laboratory 
and none of the hormones nor ACE was modified by 
H (Figs 1 and 2). In contrast, in the PAT, the 
medians of all endocrinologic measurements, with 
one exception, were elevated significantly when com- 
pared to those of the REF on either test day (Figs 1 
and 2). The augmentations of the medians were 
1.8-fold for ADR, 1.3-fold for NOR, 5.4-fold for 
INS, 18.8-fold for CP, 11.9-fold for ANP, 9.0-fold 
for PRA, 3.0-fold for PA, 8-fold for ACE and 
1.9-fold for CORT compared to the REF on H day 
(at least * for all comparisons; Figs 1 and 2). The 
only exception was ET, whose median concentration 
in peripheral venous blood was diminished in the 
PAT by about 40% compared to the hypoxic REF 
(**); (Fig. 1). All individual endocrinologic measure- 
ments referring to the PAT group were considerably 
broader spread than those on the REF group. This 
necessitated the use of logarithmic scales in Figs 1 
and 2, which tends to diminish the differences 
between the PAT and the REF optically. 
Glucose in the PAT amounted to 157 (range: 426) 
mg ‘dl ~ ’ and differed significantly from the measure- 
ments in the REF with 88 (range: 27) mg dl- ’ on N 
day (***) and 87 (range: 63) mg dl- ’ (***) on H day. 
The median of lactate was still in the range of 
normality but was increased significantly in the PAT 
with 1.36 (range 2.93) mmol l- 1 compared to the 
REF with 1.01 (range: 1.21) mmoll-’ on N day 
(***) and with 0.86 (range: 1.11) mmol l- ’ on H day 
(***). The leucocytes were elevated significantly in 
the PAT with 16.3 (range: 18.0) ,u- ’ compared to 
the REF with 5.5 (range: 3.9) ~1~ 1 on N day (***) 
and with 5.9 (range: 4.2) ,u- ’ on H day (***). 
The median heart rate amounted to 115 (range: 62) 
beats min ~ 1 in the PAT and was elevated signifi- 
cantly compared to the REF with 68 (range: 51) 
beats min - ’ on N day and 71 (range: 35) 
beats min - ’ on H day (*** for both comparisons). 
Systolic blood pressure amounted to 120 (range: 85) 
mmHg in the PAT and 125 (range: 30) mmHg in the 
REF on N day, as well as 130 (range: 10) on H day, 
without any statistically significant differences be- 
tween the medians. In the PAT, the lowest measure- 
ment was 95 mmHg. Diastolic blood pressure was 80 
(range: 64) mmHg in the PAT and 80 (range: 20) 
mmHg in the REF on N day and 85 (range: 10) 
mmHg on H day, again without any significant 
differences between the medians. The median values 
in the REF of glucose, lactate, the leucoytes, body 
temperature, heart rate, and systolic and diastolic 
blood pressure did not differ significantly between N 
day and H day. 
Body temperature in the PAT was 39.4 (range: 1.4) 
OC, contrasting to normal values in the REF on both 
test days, without exception. 
Discussion 
The findings in the patients of this investigation 
essentially corroborate the observation that critical 
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Fig, 2 Comparisons of renin (PRA), angiotensin-converting enzyme (ACE), aldosterone (PA), insulin (INS), c-peptide 
(CP) and cortisol (CORT) between the groups of the acutely hypoxaemic patients (PAT) and the reference group (REF) on 
H day (H) and on N day (N), respectively. The horizontal lines in the scatter plots indicate the positions of the medians. See 
text for statistical symbols. Note that logarithmic scales were used on the ordinate. 
illness can be associated with sizeable modifications 
in the circulating hormones (23,24). However, the 
extent of the endocrine modifications in this study 
made the authors doubt that these changes could be 
attributed exclusively to acute hypoxaemia. In order 
to clarify this problem, a healthy reference group 
was investigated additionally with experimentally- 
induced acute hypoxaemia. A synoptical comparative 
analysis of the endocrinologic measurements in both 
groups investigated does not imply that the relevant 
modifications in the patients are attributable pre- 
dominantly to acute arterial desaturation. However, 
since no previous endocrinologic measurements in 
the patients had been conducted, the data of this 
study do not exclude the possibility that the hormo- 
nal changes registered reflect a specific pathophysi- 
ological characteristic of the group of individuals 
investigated, and not of the clinical disorder its 
members were selected to represent. But even assum- 
ing that a pathological reaction to acute hypoxaemia 
might have been present in the patients, other influ- 
ences, first those connected with various aspects of 
the methodology and the experimental circumstances 
of this clinical investigation, need to be considered. 
Similarly to a number of studies on a variety of 
clinical disorders which were conducted in an inten- 
sive care setting, this investigation is afflicted with 
methodologic problems, in the first place connected 
with the process of compiling the study groups. 
The patients of this investigation reflect the broad 
scope of cases admitted to an ICU for acute hypox- 
aemic respiratory failure, although not selected 
specifically for this purpose. This sample, however, 
cannot be considered ‘representative’ in a strict stat- 
istical sense, since data on the totality of relevant 
patients are not available. In contrast, the reference 
606 T. Kullmer et al. 
group was compiled to resemble groups of subjects 
which had been previously investigated under exper- 
imental hypoxaemia, mostly at high altitude, and 
from which the current knowledge about hypoxae- 
mia was derived. Since the normal values of those 
hormones which were measured are not influenced by 
age, or dependent on physical characteristics such as 
body mass or height, influences of these variables can 
be excluded as the causes of the endocrinologic 
modifications seen in the patients of this investigation 
or the differences between the groups. Moreover, the 
age characteristics of the healthy reference group 
primarily ruled out any potential influence of internal 
diseases upon the endocrine measurements in this 
group. 
Both the raised body temperatures and the 
elevated white blood cell counts in the group of 
hypoxaemic patients prove the presence of infection, 
and confirm the initial radiologic and clinical diag- 
nosis of pneumonia, i.e. a primarily respiratory origin 
of acute arterial desaturation. In addition, the 
slightly increased values of lactate in the patients 
compared to the normal values on both test days in 
the reference group, despite a comparable severity of 
hypoxaemia, indicate an increase in anaerobic tissue 
metabolism in the first group. This supports the 
notion that sepsis was present in some of the patients. 
With elevated median values for heart rate (corre- 
sponding to the increased catecholamines) in the 
group of patients as a whole, individual patients with 
septicaemia exhibited extensive tachycardia together 
with systolic blood pressure values in the lower range 
of normality. This seems to indicate that in these 
persons, an impairment of cardiocirculatory func- 
tion, most probably of septic origin, was present. In 
turn, the latter also corroborates the notion of sepsis 
and might indicate that in these individuals, acute 
hypoxaemia could not only be attributable to a 
pulmonary impairment, but also to a cardiocircula- 
tory impairment. The higher variability of the PaO, 
measurements in the patients additionally implies 
that the severity of hypoxaemia was less homo- 
geneous than in the reference group, despite similarly 
reduced medians. 
Although, on admission, only the clinical anam- 
nesis with respect to the onset of dyspnoea was 
available to determine the duration of hypoxaemia, 
a synoptical analysis of other clinical symptoms 
pertaining to the natural course of the underlying 
clinical disorder also corroborates that hypoxaemia 
in the patients had set in acutely, i.e. during the day 
upon which the investigation was started. The some- 
what dissimilar duration of acute hypoxaemia in the 
patients and the reference group cannot be consid- 
ered a relevant influence upon the endocrinologic 
differences between the groups. In particular, those 
hormones which are known to reflect various kinds 
of stress, e.g. the catecholamines and cortisol, are 
known to react very rapidly (within a few minutes) to 
relevant stimuli. However, in the reference group, 
these hormones were not modified with acute hypox- 
aemia of the severity and the duration seen in this 
investigation. 
Moreover, although the median lactate in the ref- 
erence group on N day was slightly elevated com- 
pared to H day, the difference was not statistically 
significant and thus the result of stochastic variation. 
In summary, it seems implausible that differences 
in the duration or severity of acute hypoxaemia 
between the test persons and the patients could alone 
account for the sizeable endocrinologic dissimilarities 
between the groups. 
The measurements of PaCO, and pH prove that 
a ventilatory or an acid-based influence upon the 
medians of the hormones, especially upon the 
catecholamines (25,26), can be ruled out in the refer- 
ence group. Neither do ventilatory and acid-base 
modifications suffice to explain the vast extent of the 
endocrine modifications seen in the patients. 
Elevated levels of the catecholamines have been 
registered previously in patients with chronic pulmo- 
nary failure (27). Since adrenaline and noradrenaline 
were not modified by acute hypoxaemia in the refer- 
ence group, it seems implausible that differences 
between them and the patients could account for the 
sizeable endocrine dissimilarities between the groups, 
for example, via hormonal interactions (28). How- 
ever, the elevated levels of adrenaline in particular, 
together with the increased concentrations of cortisol 
in the patients of this study can be interpreted as 
signifying severe mental, in addition to hypoxaemic, 
stress. The augmented median concentrations of 
insulin and c-peptide in this group basically coincide 
with elevated median concentrations of blood glu- 
cose, the main stimulus of basal insulin secretion. The 
elevated median glucose concentrations in turn can 
be attributed to the increases in the medians of 
cortisol and the catecholamines (29). However, the 
vast increase in the median insulin levels could also 
be compatible with a resistance to insulin, which 
has been registered previously with acute infections 
(30) similar to the one seen in the patients of this 
study. 
The augmentation of the median levels of ANP 
supports findings on a modification of the peptide’s 
concentrations caused by acute damage to pulmo- 
nary tissue as well as reports about modifications of 
the peptide seen with decompensated obstructive 
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pulmonary disease (31,32). The sizeable increases in 
the median of this peptide would also match the 
increases in the medians of renin and aldosterone, 
together with those of the median of ACE in the 
acutely hypoxaemic patients, since a functional inter- 
action of the peptide with these hormones has 
already been registered in patients with obstructive 
lung disease (33,34) and in hypoxaemic test persons 
(35). Therefore, the increases in ACE seen in this 
investigation reflect the presence of pulmonary 
inflammation most plausibly (36). Both in contrast to 
the measurements in the hypoxaemic test persons of 
this study and to previous clinical observations on 
acute and serious infections (37), and despite its 
documented role in the pathophysiology of some 
pulmonary diseases (3X), the concentrations of ET 
measured in the peripheral venous blood of the 
hypoxaemic patients of this investigation were not 
increased. However, about 80% of ET production is 
supposedly released abluminally, with the peptide 
acting primarily as an autocrine-signalling factor 
promoting local vasoconstriction, and 20% is 
secreted intravasally. Furthermore, there is a high 
clearance rate of unbound ET in the lung and in the 
kidneys. Endothelin-I concentrations are highest at 
their site of secretion and thus are locally active as a 
vasoconstrictor. Therefore, it must be assumed that 
ET measured in a peripheral vein only reflects a local 
spill-over and thus is not representative of the total 
ET production. 
In summary, the endocrine reactions encountered 
in the hypoxaemic patients of this investigation 
must be assumed to represent a mixture of various 
influences. However, the experimental part of this 
investigation implies that acute hypoxaemia of the 
severity and duration registered in these patients 
seems to play a subordinate role, if any at all, for the 
endocrine modifications. Since the presence of acute 
infection was proven in the patients, at least some of 
the endocrine modifications in this group can be 
attributed directly to septicaemia, which is also the 
primary cause of the acute arterial hypoxaemia in 
this investigation (39). However, the above constella- 
tion in the hypoxaemic patients, especially with 
respect to the catecholamines, strongly suggests the 
additional presence of an unspecific endocrinologic 
epiphenomenon associated with admission to the 
ICU, such as severe mental stress. This last condition 
is one which all endocrinologic investigations on 
critically ill patients can be assumed to be afflicted. In 
this investigation, the phenomenon became clearly 
evident and demonstrable only through the 
additional investigation of a hypoxaemic reference 
group under similar experimental conditions. 
More indirectly, the results of this clinical investi- 
gation suggest that since hormones determined in 
critically ill patients at an ICU are largely subject 
to a variety of unspecific influences, their diag- 
nostic value under these circumstances, especially in 
non-endocrine disease, will have to be critically 
reappraised. In addition, in this study the endocrino- 
logic measurements conducted in the healthy test 
persons with acute experimental hypoxaemia cannot 
serve as a model for the pertinent reactions in the 
severely ill patients admitted to an ICU for acute 
hypoxaemia. This study also supports the notion that 
hormones measured in healthy hypoxaemic subjects 
can serve only as a yardstick for the normal endo- 
crine acclimatization reaction to acute pure ‘hypoxic’ 
hypoxaemia. 
Conclusions 
In conclusion, considerable increases in the cat- 
echolamines, ANP, renin, aldosterone, ACE, insulin, 
c-peptide and cortisol along with a slight decrease in 
ET levels in peripheral blood can be registered in 
severely ill patients admitted to an ICU for acute 
hypoxaemic respiratory failure. However, such 
modifications cannot be considered to be exclusively 
attributable to acute arterial hypoxaemia. The under- 
lying clinical disorder, such as septicaemia, or an 
unspecific endocrine epiphenomenon associated 
with admission to an ICU, such as severe stress, seem 
to be of major importance for these endocrine 
modifications. 
References 
1. 
2. 
3. 
4. 
5. 
6. 
Fontana F, Bernardi P, Pith EM et al. Relationship 
between plasma atria1 natriuretic factor and opoid 
peptide levels in healthy subjects and in patients with 
acute congestive heart failure. Eur Heart J 1993; 14: 
219-225. - 
Ross RJ, Miell JP, Holly JM et al. Levels of GH 
binding activity, IGFBP-1, insulin, blood glucose and 
cortisol in intensive care patients. Clin Endocrinol 1991; 
35: 361-367. 
Nakamura M, Arakawa N, Yoshida H et al. Increased 
plasma endothelin concentrations in patients with acute 
heart failure after myocardial infarction. Jpn Circ J 
1993: 57: 371-378. 
Weitzberg E, Lundberg JM, Rudehill A. Elevated 
plasma levels of endothelin in patients with sepsis 
syndrome. Circ Shock 1991; 33: 222-227. 
Raff H, Findling JW. Aldosterone control in critically 
il l patients: ACTH, metoclopramide, and atria1 natri- 
uretic peptide. Crit Care Med 1990; 18: 915-920. 
Block RE. Oxygen therapy. In: Fishman AP, ed. 
Pulmonary Diseases and Disorders, 2nd edition. New 
York: McGraw-Hill, 1988; pp. 2317-2330. 
608 T. Kullrnev et al. 
I. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
Mitaka C, Nagura T, Sakanishi N, Tsunoda Y, 
Toyooka H. Plasma alpha-atria1 natriuretic peptide 
concentrations in acute respiratory failure associated 
with sepsis: preliminary study. Crit Care Med 1990; 18: 
1201-1203. 
Mitaka C, Hirata Y, Nagura T, Tsunoda Y, Amaha K. 
Circulating endothelin-1 concentrations in acute respir- 
atory failure. Chest 1993 104, 476480. 
Westendorp RG, Ross AN, Walma ST, Frolich M, 
Meinders AE. Preexisting cardiopulmonary disease 
attenuating the atria1 natriuretic peptide response. 
Results in patients with acute respiratory failure. Chest 
1992; 102: 1758-1763. 
Lang CC, Coutie WJ, Struthers AD, Dhillon DP; 
Winters JH, Lipworth BJ. Elevated levels of brain 
natriuretic peptide in acute hypoxaemic chronic 
obstructive pulmonary disease. Clin Sci C&h 1992; 83: 
529-533. 
Skwarski K, Lee M, Turnbull L, MacNee W. Atria1 
natriuretic peptide in stable and decompensated chronic 
obstructive pulmonary disease. Thorax 1993; 48: 730- 
135. 
Sawhney RC, Malhotra AS, Sing T. Glucoregulatory 
hormones in man at high altitude. Eur J Appl Physiol 
1991; 62: 286-291. 
Milledge JS. Renin-aldosterone system. In: West JB, 
Sakhamay Lahiri, eds. High Altitude and Man. 
Baltimore, Maryland: Williams and Wilkins, 1984, 
pp. 47-57. 
Humpeler E, Skrabal F, Bartsch G. Influence of expo- 
sure to moderate altitude on the plasma concentra- 
tions of cortisol, aldosterone, renin, testosterone and 
gonadotropins. Eur J Appl Physiol 1980; 45: 177-183. 
Luft UC. Laboratory facilities for adaptation research: 
low pressure. In: Dill DB, ed. Handbook of physiology. 
Sect. 4, Adaptation to the Environment. Washington: 
American Physiological Society, 1964, pp. 329-341. 
Rolleri E, Zannino M, Orlandini S. Malvano R. Direct 
immunoassay of plasma cortisol. &in Chim Acta 1985; 
66: 319-330. 
Anderson JV, Bloom ST. Natriuretic peptide: what is 
the excitement all about? J Endocrinol 1986; 110: 7-17. 
Nakamura M, Arakawa N; Yoshida H et al. Sensitive 
calorimetric assay for ACE in serum. Clin Chem 1983; 
29: 1399-1403. 
DaPrada M, Ziircher G. Simultaneous radioenzymatic 
determination of plasma and tissue adrenaline, 
noradrenaline and dopamine within the femtomole 
range. Life Sci 1976; 19: 1161-1174. 
No11 FL. Lactate. In: Berkemeyer HW, ed. Methods of 
Enzymatic Analysis, 3rd edition, Weinheim: Verlag 
Chemie, 1984, pp. 582-585. 
Lollgen H. Kardiopulmonale Funktionsdiagnostik. 
Wehr/Baden: Verlag der CIBA-Zeitschriften, 1990, 
pp. 15-89. 
Roskamm H, Samek L, Weidemann H, Reindell H. 
Leistung und Hohe. Ludwigshafen am Rhein: Knoll, 
1968, pp. 19-39. 
Dahn MS, Lange P. Hormonal changes and their 
influence on metabolism and nutrition in the critically 
ill. Intensive Care Med 1982; 8: 209-214. 
24. 
25. 
26. 
27. 
28. 
29. 
30. 
31. 
32. 
33. 
34. 
35. 
36. 
37. 
38. 
39. 
Semple CG. Hormonal changes in non-endocrine dis- 
ease. BMJ 1986; 293: 104991052. 
Aurich JE; Dobrinski I, Petersen A, Grunert E, Rausch 
WD, Chan WW. Influence of labor and neonatal 
hypoxia on sympathoadrenal activity and methionine 
enkephalin release in calves. Am J Vet Res 1993; 8: 
1333-133s. 
Kivela M, Scheinin M, Lindgren L. Hemodynamic and 
catecholamine responses to- induction of anaesthesia 
and tracheal intubation in diabetic and non-diabetic 
uraemic patients. Br J Anaesth 1995; 1: 60-65. 
Henriksen JH, Christensen NJ, Kok-Jensen A, 
Christiansen I. Increased plasma noradrenaline concen- 
trations in patients with chronic obstructive lung dis- 
ease: relation to hemodynamics and blood gases. &and 
J Clin Lab Invest 1980: 40: 419427. 
Jarhult J, Holst J. The role of the adrenergic innerva- 
tion to the pancreatic islets in the control of insulin 
release during exercise in man. Pjiigers Arch 1979; 383: 
4145. 
Mayhew DA, Wright PH, Ashmore J. Regulation of 
insulin secretion. Pharmacol Rev 1969; 21: 1833212. 
Virkamaki A, Puhakainen I, Koivisto VA, Vuorinen- 
Markkola H, Yki-Jarvinen AD. Mechanisms of 
hepatic and peripheral insulin resistance during acute 
infections in humans. J Clin Endocrinol Metab 1992: 
14673-679. 
Bartsch P, Shaw S, Franciolli M, Gnaedinger MP, 
Weidmann P. Atria1 natriuretic peptide in acute 
mountain sickness. J Appl Physiol 1988; 65: 19299 
1937. 
Skwarski K, Lee M, Turnbull L, MacNee W. Atria1 
natriuretic peptide in stable and decompensated 
chronic obstructive pulmonary disease. Thorax 1993; 
48: 730-735. 
Carlone S, Palange P, Mannix ET et al. Atria1 natri- 
uretic peptide, renin and aldosterone in obstructive lung 
disease and heart failure. Am J Med Sci 1989; 298: 
243-248. 
Raff H, Levy SA. Renin-angiotensin-aldosterone and 
ACTH-cortisol control during acute hypoxemia and 
exercise in patients with chronic obstructive lung dis- 
ease. Am Rev Resp Dis 1986; 133: 396-399. 
Milledge JS. Angiotensin-converting enzyme and 
hvvoxia. Eur Phvsiopathol Resair 1984; 20: 481485. 
Wmterbauer RH, Hammar SP: Sarcoidosis and pulmo- 
nary fibrosis: a review of recent events. In: Simmons H, 
ed. Current Pulmonology Volume 7. Chicago: Year 
Book Medical Publishers, 1986, pp. 117-163. 
Ozdemir S, Saatci U, Besbas N, Bakkaloglu A, Ozen S, 
Koray Z. Plasma atria1 natriuretic peptide and endo- 
thelin levels in acute poststreptococcal glomerulone- 
phritis. Pediatr Nephrol 1992; 6: 519-522. 
Filep JG. Endothelin peptides: biological actions and 
pathophysiological significance in the lung. Life Sci 
1993; 52: 119-133. 
Frayn KN. Hormonal control of metabolism in trauma 
and sepsis. Clin Endocrinol 1986; 24: 577-599. 
